Stem cell persistence in chronic myeloid leukemia
نویسندگان
چکیده
منابع مشابه
role of stem cell elements in chronic myeloid leukemia
evidence acquisition the fifty two significant articles discussing the stem cell in chronic myeloid leukemia from 1996 to 2012 were selected according to the authors’ experience. results studies have shown that primitive cml cells are less responsive to tyrosine kinase inhibitors (tkis) and are a reservoir for the relapse of multi drug resistant (mdr). conclusions following that, minimal residu...
متن کاملStem Cell Biomarkers in Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a clonal multi-step myeloproliferative disease that is initially produced and ultimately sustained by a rare subpopulation of BCR-ABL+ cells with multi-lineage stem cell properties. These BCR-ABL+ CML stem cells are phenotypically similar to normal hematopoietic stem cells which are also maintained throughout the course of the disease at varying levels in diffe...
متن کاملchronic myeloid leukemia as a stem cell-derived malignancy
chronic myeloid leukemia (cml) is a myeloproliferative disease of the hematopoietic stem cells, characterized by the presence of the philadelphia (ph) chromosome. although imatinib inhibits the bcr-abl kinase activity, clinical experiences confirm that imatinib may not target cml stem cells in vivo. the identification of signaling pathways responsible for the self-renewal properties of leukemic...
متن کاملChronic Myeloid Leukemia Stem Cell Biology
Leukemia progression and relapse is fueled by leukemia stem cells (LSC) that are resistant to current treatments. In the progression of chronic myeloid leukemia (CML), blast crisis progenitors are capable of adopting more primitive but deregulated stem cell features with acquired resistance to targeted therapies. This in turn promotes LSC behavior characterized by aberrant self-renewal, differe...
متن کاملLeukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease.
Sustained undetectable molecular residual disease (UMRD) is obtained in a minority of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. It remains unclear whether these patients are definitively cured of their leukemia or whether leukemic stem cells (LSCs) persist in their BM. We have evaluated the presence of BCR-ABL-expressing marrow LSCs in 6 patients with chron...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Leukemia Supplements
سال: 2012
ISSN: 2044-5210,2044-5229
DOI: 10.1038/leusup.2012.24